Building off the 6-methoxy modification, the investigators utilized a linkage at that position to connect the pharmacophore for FAP to DOTA for the chelation of a radiometal/metal, either 68Ga [1,2] or [18F]AlF [17,18,19,20], with the choice not affecting tumor uptake in xenograft models. The gene discussed is FAP; the disease is neoplasm.